New Delhi, Dec 20 () Drug maker Glenmark Pharmaceuticals on Friday said that it has received approval from Australian regulator Therapeutic Goods Administration (TGA) to commercialise Ryaltris in ...

Pharma major Glenmark Pharmaceuticals Limited on Monday announced the launch of Ryaltris-AZ nasal spray for the treatment of moderate to severe allergic rhinitis, in India. Glenmark has been the ...

Ryaltris has conditionally accepted as the brand name for GSP 301 Nasal Spray by the US Food & Drug Administration (FDA). Glenmark plans to submit the companys first new drug application (NDA ...

Glenmark Pharmaceuticals has witnessed a significant ... and a decent ramp-up in the recently launched novel product, Ryaltris," said Vishal Manchanda, senior vice president, Institutional ...

The first recall affects 45,504 bottles of Ryaltris (olopatadine hydrochloride and mometasone furoate) Nasal Spray. Glenmark ...